MT Newswires
BioNTech, Bristol Myers Report Early Breast Cancer Tumor Response Data for Experimental Antibody Treatment
📊
AI Sentiment
Positive
6/10
BioNTech SE News
Latest updates and market news for BNTX
7 news
Dec 4 - Dec 10, 2025
Page 1
MT Newswires
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Monday Amid Interest Rate Cut Hopes
âž–
AI Sentiment
Neutral
5/10
MT Newswires
BioNTech, OncoC4 Say Lung Cancer Phase 3 Trial Shows 'Meaningful' Overall Survival Benefit; Shares Up Pre-Bell
âž–
AI Sentiment
Neutral
5/10
GlobeNewswire
BioNTech and OncoC4 Announce Clinically Meaningful Overall Survival Benefit for Selective Treg Modulator Gotistobart in Patients with Previously Treated Squamous Non-Small Cell Lung Cancer
📈
AI Sentiment
Highly Positive
8/10
Share this news page